Featured Articles
HotFeb 3, 2023
Hot Coming Soon, The RSV Vaccines
Respiratory syncytial virus (RSV) is a significant contributor to infant mortality with limited prevention and treatment options. The fusion glycoprotein of RSV is thought as an ideal target for vaccine R&D, which exists in pre- and post-fusion forms. Due to their different performance in inducing n
Read more
HotDec 26, 2022
Hot Evaluating Inhaled Aerosol Vaccines: No-needle COVID-19 Protection?
The COVID-19 epidemic has now entered its third year with its effects still being felt across the world. In many countries, there have been an alarming trend of waning vaccine efficacy paired with the emergence of variants with stronger immune escape and transmission ability. This consistent challen
Read more
HotNov 8, 2022
Hot COVID-19 vaccine development and its implications for the future of vaccines
COVID-19 vaccine development against the pandemic, biopharmaceutical reagents and services support infectious diseases research
Read moreExplore by Subtopics
Get ACRO Insights in Your Inbox
Receive expert perspectives, research trends, and workflow guidance across emerging therapeutic fields.
